{"id":15369,"date":"2021-09-03T08:51:11","date_gmt":"2021-09-03T08:51:11","guid":{"rendered":"https:\/\/clinlabint.com\/?p=15369"},"modified":"2021-09-13T14:46:30","modified_gmt":"2021-09-13T14:46:30","slug":"xyall-launches-tissector-high-throughput-system-a-world-first-automated-tissue-dissector","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/xyall-launches-tissector-high-throughput-system-a-world-first-automated-tissue-dissector\/","title":{"rendered":"Xyall launches Tissector High Throughput system, a world-first automated tissue dissector"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Xyall launches Tissector High Throughput system, a world-first automated tissue dissector<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Xyall BV, a leading medtech innovator in molecular pathology, has launched its Tissector High Throughput (HT) system for greater diagnostic precision. The Netherlands-based company says this is a world first \u2013 enabling high volume, molecular diagnostic laboratories to capitalize commercially on the company\u2019s unique, automated, tissue dissection technology<\/strong><\/p>\n

<\/p>\n

Xyall\u2018s Tissector HT solution uses state-of-theart technology, image registration, robotics and workflow optimization. It is designed for continuous operation and is fully integrated with digital pathology solutions and the laboratory workflow system (LIMS). The Tissector HT can hold 1,800 slides, dissect a minimum of 80 dissection slides per hour with an accuracy of < 0.1 mm and is designed for three hours unattended operation. The system is easy to use, combining high throughput with the highest accuracy.<\/p>\n

Tissue dissection, even in large-scale commercial labs, remains a manual, labour-intensive process at risk of error and cross contamination. \u201cThe Xyall solution provides the missing link for customers,\u201d explained Guido Du Pree, Xyall\u2019s CEO.<\/p>\n

Current practice involves manually pen marking Regions of Interest (ROIs) on Hematoxylin & Eosin (H&E) stained slides. Using visual assessment, lab technicians then translate these ROIs into dissection slides, manually scraping the tissue and placing it in small containers.<\/p>\n

\u201cXyall has already won contracts for order-tobuilt systems from two of the largest laboratories in the US, with high levels of interest from other molecular diagnostic laboratories requiring industrial-sized platforms,\u201d said Du Pree.<\/p>\n

\u201cWith new therapies coming to the market, and transformative technologies in PCR and next generation sequencing, precision medicine is being revolutionized \u2013 providing physicians and patients with the highest quality information about their health.<\/p>\n

\u201cHowever, tissue dissection to enable molecular profiling is still a labour intense, subjective process. Our pioneering technology transforms how this is done \u2013 delivering greater accuracy, consistency and overall improved quality control.\u201d<\/p>\n

\u201cHowever, tissue dissection to enable molecular profiling is still a labour intense, subjective process. Our pioneering technology transforms how this is done \u2013 delivering greater accuracy, consistency and overall improved quality control.\u201d<\/p>\n

Alongside the new large-scale, industrial system, Xyall is developing a smaller, table-top version for hospital-based molecular pathology laboratories. Based on the same technology, the company expects to have this second system commercially available in Q1 2022.<\/p>\n

Du Pree added: \u201cWorldwide shortages of experienced pathology staff are already putting labs under pressure. The Xyall solution will address this, helping customers to make more efficient use of existing, and increasingly scarce, staffing levels.\u201d<\/p>\n<\/div><\/section>
\n

\n
<\/span><\/span><\/div>
\n